Professor Tang Anzhou, executive director of the Chinese Medical Doctor Association's Otolaryngology branch and vice president of Guangxi Medical University, told reporters that there will be more than 30,000 hearing-impaired children each year in China. Hearing impairment can seriously affect the lives of patients, especially children, because hearing impairment affects their language development. "So, hearing loss should be prevented, early discovered, and treated early. Mild hearing impairments can be treated with hearing aids; moderate and severe hearing impairments require an implantable hearing solution such as a cochlear implant."
Tang Anzhou said: “According to statistical data, over 74.8% of children with hearing loss in Guangxi belong to severe losses. According to the clinical standards of countries such as the United States and Australia, this group of people may return to sound by implanting a cochlear implant. world."
Liang Zhiwu, deputy general manager of Singapore Renxin Medical Services Co., Ltd., who is engaged in the development of the medical market for many years, told reporters that according to this method, 20,000 of the 30,000 hearing-impaired children newly added each year can be restored by implanting a cochlear implant. Hearing, which has already had a base of 27.8 million people with hearing loss in the past, of which 7.4 million people are suitable for restoring hearing through implanted cochlear implants, and the market potential is equally huge.
Liang Zhiwu said: “27.8 million people with hearing loss and 7.4 million people are implanting cochlear implants. For any company, whether it is a high-end hearing aid manufacturer or a cochlear implant manufacturer with a relatively monopolistic market position, The market potential is enormous."
The Cochlear Cochlear implant, which entered the Chinese market as early as the 1990s, has a market share of 80% in the Chinese market and 75% in the global market. Since its inception in 1981, the company’s products have been More than 100 countries have 230,000 consumers, accounting for 75% of the implantable cochlea market.
Cochlear implant market has great potential
The Australian cochlear implant, which entered the Chinese market as far back as 1995, has experienced explosive growth in recent years. On the one hand, the awareness of newborns in hearing screening for newborns is constantly improving. On the other hand, the entire medical system that is being gradually established in Chinese society is undoubtedly the most potential space for this market development.
Mason, the general manager of Australia's Coleman Greater China, told reporters in an interview that this group of data: In the last five years, the accumulated number of implants of the Australian Cochlear cochlear implant in patients with severe deafness in China has been five years ago. The number of 2,300 people increased to 8,500 in 2010, an increase of nearly three times.
In fact, the great potential of the Chinese market does not stop there. According to the results of the National Second People's Handicapped Sample Survey, there are 27.8 million people with hearing impaired in China, of whom 137,000 are hearing impaired children aged 0 to 6 years, and 84% are severely hearing impaired children.
Huge profits foreign enterprises monopoly
Sima Qiang, a salesman of Taiwan Guangqiang Medical Service Co., Ltd., who is engaged in research and development and marketing of medical devices all the year round, told reporters that as a monopoly enterprise with independent intellectual property rights, the large profits make many people hard to imagine. He said: "The products of cochlear implants are only occupied by Australia's C ochlear (early cochlear implants), American A dvancedBionics, and Austrian M ED-EL's products. It is difficult for us to evaluate this technology from R&D and design. On the entire production chain of production, consumption, services, etc., the profits that can ultimately be obtained, but we are very clear that there is no doubt that the profit is high."
Earth companies staged "The Jedi Counterattack"
The huge market space and the “high-end occupancy rate†of foreign companies in the Chinese market have made domestic domestic companies increasingly aware of the huge appeal of this market. After spending more than 10 years on the ground, China’s local companies have tried hard to get a piece of the cake.
Not long ago, Shanghai Lisheng Special Medical Science and Technology Co., Ltd. obtained the medical device registration certificate issued by the State Food and Drug Administration of the cochlear implant. Xu Lihong, vice chairman of Hainan Pharmacy, said in an interview with the media that the production of artificial cochlea It is more applicable to the "Chinese Language Department" and the imported artificial cochlea is still based on English research and development.
At present, Hainan Haiyao, a listed company that has obtained a cochlear implant certificate, is taking this opportunity to try new IPOs. Industry insiders believe Hainan Haipiao will occupy 51% of Shengte Special Shares and become a controlling shareholder. The completion of additional issuance not only enables the cochlear implant project to be successfully put into operation and sales, but also enables the company to achieve great development in the pharmaceutical field, especially in the field of high-end antibiotics.
It is expected that Lisheng Special Cochlear Implant (adult treatment) will be put into production and sales in the second half of 2011. After three years of market development, the annual sales may reach approximately 10,000 units in 2014, achieving a sales revenue of approximately 340 million yuan and a profit of 100 million yuan. about.
According to industry estimates, the price of a set of imported cochlear implants is as high as 170,000 to 200,000 yuan. If domestic cochlear implants are used, they only need about 60,000 yuan, and the price is only one third to two of the imported cochlear implants. One in a minute. In accordance with the domestic market's many years of practice, if the domestic cochlear implant can go to market and get market recognition, 'catfish effect' will certainly stimulate the price of imported cochlear implants.
Tang Anzhou said: “According to statistical data, over 74.8% of children with hearing loss in Guangxi belong to severe losses. According to the clinical standards of countries such as the United States and Australia, this group of people may return to sound by implanting a cochlear implant. world."
Liang Zhiwu, deputy general manager of Singapore Renxin Medical Services Co., Ltd., who is engaged in the development of the medical market for many years, told reporters that according to this method, 20,000 of the 30,000 hearing-impaired children newly added each year can be restored by implanting a cochlear implant. Hearing, which has already had a base of 27.8 million people with hearing loss in the past, of which 7.4 million people are suitable for restoring hearing through implanted cochlear implants, and the market potential is equally huge.
Liang Zhiwu said: “27.8 million people with hearing loss and 7.4 million people are implanting cochlear implants. For any company, whether it is a high-end hearing aid manufacturer or a cochlear implant manufacturer with a relatively monopolistic market position, The market potential is enormous."
The Cochlear Cochlear implant, which entered the Chinese market as early as the 1990s, has a market share of 80% in the Chinese market and 75% in the global market. Since its inception in 1981, the company’s products have been More than 100 countries have 230,000 consumers, accounting for 75% of the implantable cochlea market.
Cochlear implant market has great potential
The Australian cochlear implant, which entered the Chinese market as far back as 1995, has experienced explosive growth in recent years. On the one hand, the awareness of newborns in hearing screening for newborns is constantly improving. On the other hand, the entire medical system that is being gradually established in Chinese society is undoubtedly the most potential space for this market development.
Mason, the general manager of Australia's Coleman Greater China, told reporters in an interview that this group of data: In the last five years, the accumulated number of implants of the Australian Cochlear cochlear implant in patients with severe deafness in China has been five years ago. The number of 2,300 people increased to 8,500 in 2010, an increase of nearly three times.
In fact, the great potential of the Chinese market does not stop there. According to the results of the National Second People's Handicapped Sample Survey, there are 27.8 million people with hearing impaired in China, of whom 137,000 are hearing impaired children aged 0 to 6 years, and 84% are severely hearing impaired children.
Huge profits foreign enterprises monopoly
Sima Qiang, a salesman of Taiwan Guangqiang Medical Service Co., Ltd., who is engaged in research and development and marketing of medical devices all the year round, told reporters that as a monopoly enterprise with independent intellectual property rights, the large profits make many people hard to imagine. He said: "The products of cochlear implants are only occupied by Australia's C ochlear (early cochlear implants), American A dvancedBionics, and Austrian M ED-EL's products. It is difficult for us to evaluate this technology from R&D and design. On the entire production chain of production, consumption, services, etc., the profits that can ultimately be obtained, but we are very clear that there is no doubt that the profit is high."
Earth companies staged "The Jedi Counterattack"
The huge market space and the “high-end occupancy rate†of foreign companies in the Chinese market have made domestic domestic companies increasingly aware of the huge appeal of this market. After spending more than 10 years on the ground, China’s local companies have tried hard to get a piece of the cake.
Not long ago, Shanghai Lisheng Special Medical Science and Technology Co., Ltd. obtained the medical device registration certificate issued by the State Food and Drug Administration of the cochlear implant. Xu Lihong, vice chairman of Hainan Pharmacy, said in an interview with the media that the production of artificial cochlea It is more applicable to the "Chinese Language Department" and the imported artificial cochlea is still based on English research and development.
At present, Hainan Haiyao, a listed company that has obtained a cochlear implant certificate, is taking this opportunity to try new IPOs. Industry insiders believe Hainan Haipiao will occupy 51% of Shengte Special Shares and become a controlling shareholder. The completion of additional issuance not only enables the cochlear implant project to be successfully put into operation and sales, but also enables the company to achieve great development in the pharmaceutical field, especially in the field of high-end antibiotics.
It is expected that Lisheng Special Cochlear Implant (adult treatment) will be put into production and sales in the second half of 2011. After three years of market development, the annual sales may reach approximately 10,000 units in 2014, achieving a sales revenue of approximately 340 million yuan and a profit of 100 million yuan. about.
According to industry estimates, the price of a set of imported cochlear implants is as high as 170,000 to 200,000 yuan. If domestic cochlear implants are used, they only need about 60,000 yuan, and the price is only one third to two of the imported cochlear implants. One in a minute. In accordance with the domestic market's many years of practice, if the domestic cochlear implant can go to market and get market recognition, 'catfish effect' will certainly stimulate the price of imported cochlear implants.
Coriander Seed Powder,Coriander Cumin Powder,Coriander Seeds To Powder,1 Tsp Coriander Seeds To Powder
jiangmen city hongsing food co., ltd. , https://www.jmhongsing.com